Pfizer Inc (WBO:PFE)
€ 24.955 -0.445 (-1.75%) Market Cap: 140.28 Bil Enterprise Value: 192.77 Bil PE Ratio: 36.11 PB Ratio: 1.64 GF Score: 74/100

Pfizer Inc at Wolfe Research Healthcare Conference Transcript

Nov 18, 2022 / 01:45PM GMT
Release Date Price: €46.72 (+0.73%)
Timothy Minton Anderson;Christopher J. Stevo
Wolfe Research, LLC - MD of Equity Research;Pfizer Inc. - Senior VP & Chief IR Officer

Yes, I'm doing a virtual fireside chat today with Pfizer. We had a 2-day in-person meeting that just finished yesterday and we've got a few more companies today. So Dave Denton, Chief Financial Officer, Executive Vice President, joined Pfizer in 2022 as the CFO succeeding Frank. Prior to Pfizer, Dave was CFO for Lowe's. And prior to that, he was the CFO for CVS, where he actually spent most of his career. So while he's new to Pfizer, he's spent more than 20 years in the health care sector. At CVS, he played a key role in kind of transforming it from a retail pharmacy to more of a broader health solutions company, and he also helped lead the integration of Caremark and played a pivotal role in CVS acquisition Aetna.

So as a result, he brings to Pfizer, a unique perspective on the role of payers. We also have Chris Stevo from Investor Relations online. And Chris, I think you wanted to make a comment about forward-looking statements.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot